anti-cd20 antibody Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (2)

Interventional (2)

Chinese University of Hong Kong (1)
The University of Hong Kong (1)

No (2)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadimmunoglobulin

I am/have/hadelisa

I am/have/hadindirect immunofluorescence

I am/have/hadpemphigus

I am/have/hadb-cell acute lymphoblastic leukemia

I am/have/hadacute lymphoblastic leukemia

I am/have/hadleukemic cells

I am/have/hadimmunoglobulins

I am/have/hadhematopoietic stem cell transplantation

I am/have/hadacantholysis

I am/have/hadremission

I am/have/haddirect immunofluorescence

I am/have/hadautoimmune disease

I am/have/hadflow cytometry

I am/have/hadmucosal biopsy

I am/have/hadcns involvement

I am/have/hadtesticular

I am/have/hadenzyme-linked immunosorbent assay

I am/have/hadleukemia

added new label for I am/have/had

more

I am looking for

I am looking forimmunoglobulin g

I am looking forimmunoglobulin

I am looking forproteasome inhibitor

I am looking fortositumomab

I am looking forpediatric

I am looking forintravenous immunoglobulin

I am looking forimmunoglobulins

I am looking forigiv

I am looking foranti-cd20 antibody

I am looking forimmunosuppressive agents

I am looking forprednisolone

I am looking forcorticosteroids

I am looking forimmunomodulators

I am looking forbortezomib injection

I am looking forrituximab

I am looking forimmunosuppressants

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For pediatric ages
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

New agents will be added aiming at improving survival outcome. Study of adding anti-CD20 antibody (rituximab) with chemotherapy: CD20 is found to be expressed in 40-50% of B-lineage ALL, and rituximab has been studied in adult ALL with superior survival (75% vs 47%,).

remission

acute lymphoblastic leukemia

bortezomib injection

proteasome inhibitor

flow cytometry

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Dermatology
Recruiting

IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus

A recent randomized trial has proved the efficacy of Rituximab, a monoclonal anti-CD20 antibody against B-lymphocytes, as an efficacious therapy for pemphigus. Early use of rituximab was associated with better clinical outcomes, hence combination treatment of rituximab and intravenous immunoglobulins (IVIG) has shown to be effective for refractory pemphigus cases …

immunoglobulin g

immunoglobulin

elisa

indirect immunofluorescence

pemphigus

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.